Ramat-Hasharon, Israel

Daniele Marciano


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 135(Granted Patents)


Company Filing History:


Years Active: 1996-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Daniele Marciano: Innovator in Cholinergic System Compounds

Introduction

Daniele Marciano is a notable inventor based in Ramat-Hasharon, Israel. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that act on the cholinergic system. With a total of 2 patents, his work focuses on innovative solutions for treating diseases affecting the central and peripheral nervous systems.

Latest Patents

Marciano's latest patents include groundbreaking work on Aza spiro compounds. These compounds are designed to treat various diseases of the central or peripheral nervous system in mammals. The first patent details compounds with specific formulae I-XII, where ring A or A' forms a bridged or unbridged ring containing one or two nitrogen atoms. The second patent focuses on spiro compounds containing five-membered rings, also aimed at treating similar diseases, with formulae I-XIII that follow a comparable structural design.

Career Highlights

Throughout his career, Marciano has worked at the Israel Institute for Biological Research, where he has contributed to various research projects. His expertise in medicinal chemistry has positioned him as a valuable asset in the field, leading to the development of innovative therapeutic compounds.

Collaborations

Marciano has collaborated with notable colleagues, including Abraham Fisher and Dov Barak. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.

Conclusion

Daniele Marciano's contributions to the field of medicinal chemistry, particularly through his patents on cholinergic system compounds, highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the development of treatments for neurological diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…